Insulet
PODD
#1094
Rank
HK$132.71 B
Marketcap
HK$1,890
Share price
-2.10%
Change (1 day)
32.84%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Operating Margin for Insulet (PODD)

Operating Margin as of March 2025 (TTM): 14.49%

According to Insulet's latest financial reports and stock price the company's current Operating Margin is 14.49%. At the end of 2024 the company had an Operating Margin of 14.49%.

Operating Margin history for Insulet from 2006 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202414.49%14.6%
202312.65%1584.25%
20220.75%-59.76%
20211.87%73.95%
20201.07%-45.4%
20191.96%112.97%
20180.92%-116.08%
2017-5.74%-21.52%
2016-7.31%-68.59%
2015-23.26%12.39%
2014-20.70%13.97%
2013-18.16%-25.68%
2012-24.44%-34.77%
2011-37.47%-40.6%
2010-63.07%-42.43%
2009-109.56%-51.33%
2008-225.11%-44.09%
2007-402.65%-57.43%
2006-945.81%-97.8%
2005-43,010.00%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-2.77%-119.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-9.18%-163.35%๐Ÿ‡บ๐Ÿ‡ธ USA
17.57% 21.26%๐Ÿ‡บ๐Ÿ‡ธ USA
18.78% 29.61%๐Ÿ‡บ๐Ÿ‡ธ USA
18.05% 24.57%๐Ÿ‡บ๐Ÿ‡ธ USA
14.94% 3.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
28.15% 94.27%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.